Forthcoming Issue

Peer review articles planned or manuscripts submitted for peer review approval and publication in the forthcoming issues.

Online First

Online First articles have been peer reviewed, accepted for publication and published online; they have not yet been assigned to a journal issue. When an article is published in a journal issue with the assigned page number, it will be removed from the ‘Forthcoming Issue’ page.

Online First articles are copyedited by the science editors and the editorial production team; typeset, proofread and approved by the author(s) before publication. We aim to post each article within six weeks of acceptance and within two weeks after final proofreading approval by the author. Online First articles are in searchable full text, with the initial online publication date included in the final print version.

Articles appearing on the ‘Forthcoming Issue’ page are in the order of the Journal Editorial Sections.  You may also view the abstract by clicking on the article link.

Subscribe now to the print or PDF copy of GaBI Journal to view full information of the following manuscripts*.

Editor’s Letter

What to look forward to in GaBI Journal, 2020, Issue 2 / Professor Philip D Walson, MD

Commentary

Importance of the determination of the higher order structure in the in-use stability studies of biopharmaceuticals / Professor Alain Astier, PharmD, PhD

Quality standards for biopharmaceuticals: the importance of good manufacturing practice / Elwyn Griffiths, DSc, PhD

Original Research

Qualitative Survey-Based Evaluation of Operability and Convenience for the Etanercept Biosimilar YLB113 in a Unique Injection Pen in Patients with Rheumatoid Arthritis / Toshihiko Hibino, Tomohiko Yoshida, Akira Sagawa, Ikuko Masuda,Takaaki Fukuda

European prescribers’ attitudes and beliefs on biologicals prescribing and automatic substitution / Madelaine Feldman, MD, FACR, Michael S. Reilly, Esq.

Review Article

Global challenges in the manufacture, regulation and international harmonization of GMP and quality standards for biopharmaceuticals/ Chong Hock Sia; Ming Kian Sia; Lai Wah Chan

Tailored development program of Pelmeg®, a biosimilar pegfilgrastim / Karsten Roth, Hendrik Wessels, Josef Höfler, Ulrike Scholz, Dirk Lehnick

Current trends for biosimilars in the Latin American market / Esteban Ortiz-Prado, Jorge Ponce-Zea, Eduardo Vasconez, Diana Castillo, Diana C Checa-Jaramillo, Nathalia Rodríguez-Burneo, Felipe Andrade, Damaris Intriago, Claudio Galarza-Maldonado

Legal

Policy recommendations for a sustainable biosimilars market: lessons from Europe / Professor Philip J Schneider, MS, FASHP, FFIP; Michael S Reilly, Esq

Regulatory

Regulatory pathway for approval of ‘biosimilars’ in Iran / Jalal Naeli, MD

Meeting Report

3rd Colombian educational workshop on regulatory assessment of biosimilars 2019 – Report

Special Report

Biosimilars markets: US and EU compared / GaBI Journal Editor

Clinical trials for trastuzumab biosimilars / GaBI Journal Editor

Research News

Poor traceability of biologicals in UK ADR reporting indicates the need for improvements to ensure patient safety / Kevin Klein, PhD

Click here for more details on the educational series.

Contact us for an updated list of editorial topics in forthcoming issues.

*Editorial content may differ from final version of manuscript published in print.

Last update: 2020-07-07 Go Back Print

Comments are closed.